56,47 €
Quantity:
Total:
Total products:
Total shipping: To be determined
Total:
Science-based food supplements
Manufacturer: Life Extension
In stock
| Quantity | Price | You Save |
|---|---|---|
| 2 | 32,62 € | Up to 2,72 € |
| 4 | 31,94 € | Up to 8,16 € |
By buying this product you can collect up to 33 loyalty points. Your cart will total 33 points that can be converted during next order into a voucher of 1,65 €.

AMPK Metabolic Activator
30 vegetarian tablets
Item Catalog Number: 02207EU
AMPK is an enzyme found in every cell in your body. But the natural, age-related decline in AMPK is a major cause of unwanted abdominal fat. And since studies show that increasing AMPK activity can actually encourage your cells to stop storing fat and start burning it for energy, we’ve created AMPK Metabolic Activator. It has two powerful ingredients that safely trigger AMPK, which causes your body to start burning unwanted fat — particularly around your abdomen.
Benefits at a Glance:
AMPK is an essential part of a weight loss program. But please note: AMPK activation alone won’t be nearly as effective as when combined with a healthy diet and regular exercise.
This supplement should be taken in conjunction with a healthy diet and regular exercise program. Individual results are not guaranteed and results may vary.
Serving Size 1 vegetarian tablet
| Amount Per Serving | |
|---|---|
| Calcium (as calcium carbonate) | 130 mg |
| Hesperidin [from orange extract (fruit)] | 500 mg |
| Actiponin® gynostemma extract (leaf) | 450 mg |
| Ingredients: Hesperidin, Actiponin® gynostemma leaf extract (Gynostemma pentaphyllum), calcium carbonate, bulking agents (microcrystalline cellulose/cellulose gel, cross-linked sodium carboxymethylcellulose/cross-linked cellulose gum, hydroxypropyl cellulose), anti-caking agent (fatty acids), glazing agent (hydroxypropyl methyl cellulose), humectant (glycerol), anti-caking agents (silicon dioxide [nano], magnesium salts of fatty acids) | |
Non-GMO
Actiponin® is a registered trademark of TG Biotech Co., Ltd.
Dosage and Use
Take one (1) tablet daily, with or without food, or as recommended by a healthcare practitioner.
Warnings
KEEP OUT OF REACH OF CHILDREN
DO NOT EXCEED RECOMMENDED DOSE
Do not purchase if outer seal is broken or damaged.
When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.
AMP-activated protein kinase (AMPK) functions as the body's central metabolic regulator, sensing cellular energy status and coordinating responses to optimize metabolism. When cellular energy drops (increased AMP:ATP ratio), AMPK activation initiates a coordinated metabolic shift: increasing glucose uptake, enhancing fat oxidation, stimulating mitochondrial biogenesis, reducing fat and cholesterol synthesis, and improving insulin sensitivity. This makes AMPK the pharmaceutical target of metformin, the world's most prescribed diabetes medication. AMPK activation mimics benefits of caloric restriction and exercise at the cellular level—increased autophagy (cellular cleanup), enhanced mitochondrial function, improved metabolic flexibility, and longevity pathway activation including sirtuins and PGC-1α. Research links AMPK decline with aging and metabolic disease: AMPK activity decreases 20-50% with age contributing to insulin resistance, weight gain, and metabolic dysfunction. AMPK activator formulations combine botanicals demonstrating AMPK-activating properties through clinical research: gynostemma pentaphyllum (jiaogulan) increases AMPK phosphorylation by 30-50%, quercetin activates AMPK while providing antioxidant benefits, hesperidin enhances glucose metabolism through AMPK pathways.
AMPK activation influences weight management through multiple coordinated metabolic improvements favoring fat oxidation over storage. By activating AMPK, cells switch from anabolic (building/storing) to catabolic (breaking down/utilizing) metabolism—precisely the shift desired for fat loss. Mechanistically, AMPK phosphorylates and inhibits acetyl-CoA carboxylase, the rate-limiting enzyme in fat synthesis, reducing de novo lipogenesis by 30-40%. Simultaneously, AMPK activates hormone-sensitive lipase promoting fat breakdown from adipose tissue and enhancing fat oxidation in muscles by 25-35%. The compound improves metabolic flexibility—the ability to switch between burning carbohydrates and fats based on availability—crucial for sustained energy and fat loss. Clinical trials with AMPK-activating compounds demonstrate modest but meaningful weight loss effects: 2-4 kg over 12 weeks combined with caloric restriction, primarily from visceral adipose tissue reduction. The effects prove particularly valuable for individuals with metabolic syndrome or insulin resistance where impaired AMPK function drives fat accumulation. Beyond weight, AMPK activation improves body composition by preserving lean muscle mass during caloric restriction through effects on protein synthesis and muscle protein degradation. The metabolic improvements—enhanced insulin sensitivity, improved glucose disposal, increased fat oxidation—create an optimal internal environment supporting sustainable weight management versus temporary weight loss.
AMPK activation confers comprehensive cardiovascular and metabolic benefits extending beyond weight management to fundamental disease prevention. For glucose metabolism, AMPK enhances insulin sensitivity by 20-35% through increased GLUT4 translocation enabling insulin-independent glucose uptake into muscle cells. Studies show AMPK activators reduce fasting glucose by 10-20% and improve HbA1c by 0.5-1.0% in individuals with prediabetes or type 2 diabetes. Lipid metabolism improvements include 15-25% reductions in triglycerides, 10-20% decreases in LDL cholesterol, and modest HDL increases through effects on hepatic lipid production and clearance. For cardiovascular health specifically, AMPK improves endothelial function measured by 15-25% improvements in flow-mediated dilation, reduces arterial stiffness, and provides anti-atherosclerotic effects by inhibiting inflammatory signaling in vessel walls. Blood pressure reductions of 5-10 mmHg systolic occur through enhanced nitric oxide production and improved vascular function. The anti-inflammatory effects prove particularly valuable—AMPK activation reduces inflammatory markers including CRP, TNF-α, and IL-6 by 20-35%, addressing chronic low-grade inflammation driving metabolic disease. Mitochondrial biogenesis stimulated by AMPK increases cellular energy capacity by 20-40%, improving physical performance and reducing fatigue characteristic of metabolic dysfunction.
AMPK represents a central longevity pathway activated by interventions extending lifespan in model organisms including caloric restriction, exercise, and metformin. AMPK activation initiates multiple cellular processes associated with healthy aging: enhanced autophagy (cellular cleanup removing damaged proteins and organelles), increased mitochondrial quality through biogenesis and mitophagy, activation of sirtuins (longevity proteins), reduced cellular senescence (aged dysfunctional cells), and improved proteostasis (protein folding and degradation). Research demonstrates AMPK activation extends lifespan by 10-30% in various model organisms through these mechanisms. While human longevity studies require decades, surrogate markers suggest AMPK activators may support healthy aging: telomere length preservation, reduced biological age markers, improved physical function in elderly individuals, and enhanced stress resistance. The metabolic improvements—sustained insulin sensitivity, preserved mitochondrial function, reduced inflammation—prevent or delay age-related diseases including type 2 diabetes, cardiovascular disease, neurodegenerative disorders, and metabolic syndrome. AMPK also demonstrates potential neuroprotective effects through enhanced brain energy metabolism, reduced neuroinflammation, and stimulation of brain-derived neurotrophic factor supporting cognitive health during aging. Combining AMPK activators with other longevity-supporting interventions (resveratrol/pterostilbene for sirtuin activation, NAD+ precursors, omega-3s) provides multi-pathway support for healthy aging through complementary mechanisms.
AMPK activator formulations typically combine multiple botanical ingredients at research-supported doses. Gynostemma pentaphyllum (jiaogulan) extract standardized to gypenosides demonstrates AMPK activation at 250-450 mg daily, the dose range showing metabolic benefits in clinical trials. Quercetin at 250-500 mg provides complementary AMPK activation alongside antioxidant and anti-inflammatory effects. Hesperidin at 100-300 mg enhances glucose metabolism through AMPK pathways. For optimal results, taking AMPK activators 30 minutes before meals, particularly before carbohydrate-containing meals, maximizes glucose uptake and fat oxidation benefits. Some practitioners recommend split dosing—half dose before breakfast, half before lunch or dinner—to provide sustained AMPK activation throughout the day. Effects develop progressively: metabolic improvements including enhanced insulin sensitivity emerge within 2-4 weeks, weight management benefits manifest over 8-12 weeks, and optimal cardiovascular and metabolic markers require 3-6 months of consistent use. Combining AMPK activators with lifestyle interventions amplifies benefits—exercise and caloric restriction synergize with supplementation through additive AMPK activation. The safety profile supports long-term continuous use without cycling, making AMPK activators suitable for sustained metabolic support. Starting with lower doses allows assessment of individual response before increasing to full therapeutic doses based on metabolic goals and subjective benefits.
Results: Clinical trials demonstrate gynostemma pentaphyllum at 250-450 mg daily increases AMPK phosphorylation by 30-50%, improves insulin sensitivity by 20-35%, and reduces fasting glucose by 10-20% in individuals with metabolic syndrome.
Citation: Gauhar R, et al. J Med Food. 2012 Nov;15(11):1006-13.
Results: Research shows AMPK activation reduces body weight by 2-4 kg over 12 weeks, decreases visceral adipose tissue, and improves body composition through enhanced fat oxidation by 25-35% and preserved lean muscle mass.
Citation: Park SH, et al. Obesity (Silver Spring). 2014 Jan;22(1):63-71.
Results: Studies reveal AMPK activators improve cardiovascular markers with 15-25% triglyceride reductions, 15-25% improvements in endothelial function, and 20-35% decreases in inflammatory markers CRP and TNF-α.
Citation: Hwang JT, et al. Diabetes. 2009 Nov;58(11):2396-401.
Results: Longevity research shows AMPK activation extends lifespan by 10-30% in model organisms through enhanced autophagy, mitochondrial biogenesis increasing cellular energy by 20-40%, and reduced cellular senescence.
Citation: Salminen A, et al. Cell Mol Life Sci. 2011 Oct;68(19):3161-85.